Answers are grounded in this paper and cite their sources.
Background Although vitamin D (VD) is chemoprotective and enhances 5-fluorouracil (5-FU) cytotoxicity against colorectal cancer (CRC), little is known about its potential calcium (Ca 2+ )-mediated anti-tumorigenic actions. Therefore, this study compared between VD and its non-calcaemic analogue, Paricalcitol (Pcal), ± 5-FU in relation to chemoprevention and Ca 2+ -mediated apoptosis in vivo and in vitro . Methods Seventy male mice were distributed to: negative controls, positive controls (PC), VD, Pcal, 5-FU, VD + 5-FU and Pcal+5-FU groups. All groups, except negative, received two consecutive azoxymethane (AOM)-injections (10 mg/Kg/week) for CRC induction. VD 3 (1000 IU/kg; three times/week) and Pcal (1.25 μg/kg; three times/week) injections started week-16 post-AOM and for 10 weeks. Three successive 5-FU cycles began at week-21 (50 mg/Kg/week). Similar protocols with VD 3 , Pcal and/or 5-FU were applied in the HT29 colon cancer cells. Results The PC group had abundant malignant tumours, markedly elevated proliferation markers (survivin/CCND1) and declines in cyclin-dependent kinase-inhibitor-1A, pro-apoptotic molecules (p53/BAX/cytochrome_C/caspase-3), tissue Ca 2+ concentrations and Ca 2+ -dependent proteins (CaSR/CAM/CAMKIIA). All monotherapies equally reduced tumour numbers and proliferation markers whilst promoting the anti-tumorigenic molecules. VD and/or 5-FU, but not Pcal monotherapy, enhanced Ca 2+ levels and Ca 2+ -related molecules (CaSR/CAM/CAMKIIA/BAX/cytochrome_C) in vivo and in vitro . However, VD + 5-FU co-therapy showed the lowest tumour numbers, the highest cell numbers in sub-G1 phase of cell cycle, alongside the most effective modulations of oncogenes , tumour suppressors and Ca 2+ -related molecules at the gene and protein levels in vivo and in vitro . Conclusions VD 3 was superior than Paricalcitol in potentiating 5-FU cytotoxicity, possibly by upregulating several Ca 2+ -related molecules involved in tumour suppression.
No takes yet. Share an insight, caveat, or question.
Aslam et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: